Abstract
Cyanobacteria (“blue-green algae”) are recognized producers of a diverse array of toxic secondary metabolites. Of these, the lipopolysaccharides (LPS), produced by all cyanobacteria, remain to be well investigated. In the current study, we specifically employed the zebrafish (Danio rerio) embryo to investigate the effects of LPS from geographically diverse strains of the widespread cyanobacterial genus, Microcystis, on several detoxifying enzymes/pathways, including glutathione-S-transferase (GST), glutathione peroxidase (GPx)/glutathione reductase (GR), superoxide dismutase (SOD), and catalase (CAT), and compared observed effects to those of heterotrophic bacterial (i.e., E. coli) LPS. In agreement with previous studies, cyanobacterial LPS significantly reduced GST in embryos exposed to LPS in all treatments. In contrast, GPx moderately increased in embryos exposed to LPS, with no effect on reciprocal GR activity. Interestingly, total glutathione levels were elevated in embryos exposed to Microcystis LPS, but the relative levels of reduced and oxidized glutathione (i.e., GSH/GSSG) were, likewise, elevated suggesting that oxidative stress is not involved in the observed effects as typical of heterotrophic bacterial LPS in mammalian systems. In further support of this, no effect was observed with respect to CAT or SOD activity. These findings demonstrate that Microcystis LPS affects glutathione-based detoxification pathways in the zebrafish embryo, and more generally, that this model is well suited for investigating the apparent toxicophore of cyanobacterial LPS, including possible differences in structure-activity relationships between heterotrophic and cyanobacterial LPS, and teleost fish versus mammalian systems.
Keywords: lipopolysaccharide, cyanobacteria, zebrafish, Microcystis, glutathione, detoxification pathways, oxidative stress
1. Introduction
Cyanobacteria, also known as “blue-green algae”, are photosynthetic bacteria that, although being ubiquitous in their distribution, are perhaps best studied in freshwater systems where they can form large, noxious and potentially toxigenic blooms. Cyanobacteria are well known to produce a diversity of toxic secondary metabolites, including hepatotoxins (e.g., microcystins, cylindrospermopsin), neurotoxins (e.g., saxitoxin, anatoxin-a), cytotoxins, dermatotoxins (e.g., lyngbyatoxin) and “endotoxins” (i.e., lipopolysaccharides), and have consequently become a growing environmental health concern (see, for example, [1]). Of the known cyanobacterial toxins, the chemically complex lipopolysaccharides (LPS) remain among the least understood, despite the fact that they are produced by all cyanobacteria.
LPS, in general, are characteristic structural components of the outer membrane of Gram-negative bacteria (including cyanobacteria), and, in the case of heterotrophic representatives, are well described as the so-called “endotoxins” associated with sepsis and related toxicoses associated with bacterial infection. Indeed, the vast majority of what is known about LPS chemistry and toxicity has been exclusively described for heterotrophic bacterial endotoxin. Structurally, LPS described from heterotrophic bacteria [2] are comprised of a lipid moiety, lipid A, typically characterized by acylated and phosphorylated glucosamine disaccharides, attached to a polysaccharide backbone, including an oligosaccharide “core”, generally characterized by heptose and 3-deoxy-D-mannooctulosonic acid (Kdo), and a variable outer polysaccharide (“O-antigen”). Toxicologically, heterotrophic bacterial LPS are primarily recognized as pro-inflammatory and immunomodulatory molecules, eliciting expression of various signaling molecules (e.g., cytokines/chemokines, eicosanoids), and release of superoxide radicals and other reactive oxygen species (ROSs), leading to oxidative stress [3,4]. Specifically, it has been well established that LPS initiation of these activities is centrally mediated via interactions between lipid A and toll-like receptor 4 (TLR4), a member of the TLR family of transmembrane proteins [5,6].
Recent research has suggested that cyanobacterial LPS may be linked to a wide variety of health effects in humans, including gastro-intestinal illness, skin rashes, allergy, respiratory disease, headache, fever, and other pathologies, however, limited studies have investigated possible mechanisms associated with these effects [7]. In recent studies [8], LPS from the cyanobacterial species, Microcystis aeruginosa, was shown to stimulate the production/release of neuroinflammation mediators, including superoxide radicals, cytokines/chemokines and eicosanoids, and various related proteins in rat brain microglia, but activities were generally only observed at considerably higher (i.e., 102–103 fold) concentrations when compared to heterotrophic bacterial LPS.
In the present study, the zebrafish (Danio rerio) embryo model was used to investigate the effects of the cyanobacterial LPS on detoxifying enzymes. For the past decade or more, the zebrafish model has been increasingly used in a growing number of research areas such as toxicological studies [9,10,11], genetic studies of development and human disease [12,13], and drug screening and discovery [14]. Among various practical advantages, zebrafish are relatively easy to maintain and breed, and the embryos are transparent and fully develop most organ systems within 96 h post-fertilization (hpf), making them an ideal vertebrate model system. With respect to the current study, the zebrafish embryo has been used previously to investigate cyanobacterial toxins generally [10,11], and cyanobacterial LPS specifically [15,16].
It has been generally established [17,18] that lower invertebrates, including fish, are (compared to mammalian systems) relatively resistant to heterotrophic bacterial LPS by conventional measures (e.g., activation of immune cells). Specifically, it has been recently suggested [19] that resistance of fish to heterotrophic bacterial LPS is likely due to evolutionary divergence of the TLR4 receptor (i.e., the “LPS receptor” in mammals). In contrast, however, a prior study by Best et al., [15] investigated the effects of cyanobacterial LPS on the detoxifying GST enyzme in embryonic D. rerio, and found that LPS from various cyanobacterial sources reduced the activity of both soluble and microsomal GST in D. rerio embryos within 24 hpf. Moreover, inhibition of GST by cyanobacterial LPS was significantly higher compared to heterotrophic bacterial (e.g., Escherichia coli, Salmonella typhimurium) LPS. These findings, therefore, suggest not only that yet uncharacterized chemical features of cyanobacterial LPS may present unique (from other bacterial) toxicophores, but also that teleost fish (such as zebrafish) represent a unique model for evaluating these compounds.
The current study focused on the effect of LPS from several, geographically diverse strains of the widespread genus, Microcystis, on several detoxification enzymes/pathways in the zebrafish embryo. Specifically we evaluated glutathione-based pathways, GST and glutathione peroxidase (GPx)/glutathione reductase (GR), as well as superoxide dismutase (SOD) and catalase (CAT) that interact directly with ROSs. To further assess the role of oxidative stress, we evaluated both the total glutathione pool, as well as exclusive and relative concentrations of reduced/oxidative glutathione (GSH/GSSG) levels.
2. Materials and Methods
2.1. Microcystis Culture and LPS Extraction
Strains of cyanobacteria belonging to the genus, Microcystis, were cultured in the Department of Biological Sciences at Florida International University (Miami, FL). Strains included those isolated from temperate freshwater systems of the Great Lakes, MC 81-11 (Bay of Quinte, Lake Ontario) and MC 95-11 (Lake Erie), and from sub-tropical South Florida, MC 36-1 (Doctors Lake, Hog Point, FL, USA), as well as a strain (299) of M. aeruginosa obtained from the reference collection of the University of Toronto Culture Collection of algae and cyanobacteria (Table 1). All isolates (except M. aeruginosa 299) were taxonomically identified (to genus) by microscopic observations using classical morphological criteria given in Komarek and Anagnostidis [20,21]. The cultures were grown in 3L flasks in BG11 medium under cool-white fluorescent light (intensity 30 µEm−2s−1) with aeration as previously described [10,11,22]. The cells were harvested after three to four weeks by centrifugation and freeze-dried.
LPS were extracted from collected cyanobacterial biomass using the standard “hot phenol-water extraction” method as modified by Bernadova et al. [23]. Briefly, freeze-dried biomass from cultures were re-suspended in pyrogen-free water, added to equal volume of 90% phenol (in water) and extracted (with stirring) at 68 °C for 20 min. The aqueous layer was removed by centrifugation (2500 g for 30 min), and the remaining phenol extracted a second time with water. The pooled aqueous fractions were dialyzed (3500 molecular weight cut-off cellulose) against distilled water, and lyophilized. The lyophilized sample was re-dissolved in 0.1 M Tris buffer with 25 µg·mL−1 RnaseA (Sigma-Aldrich, St. Louis, MO, USA), and incubated at 37 °C for 16 h. An equal volume of phenol was added to the resuspended sample, and after incubation (at room temperature for 4 min), the aqueous layer was collected by centrifugation, dialyzed a second time and subsequently lyophilized to produce the LPS in powder form. In addition to the LPS extracted from cyanobacterial biomass, a standard of LPS from Escherichia coli (0128:B12), a heterotrophic bacterium, was purchased from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Endotoxin Activity and Microcystin Content of LPS Extractions
“Endotoxin activity” is a commonly employed measure of LPS, particularly in the investigation of heterotrophic bacteria, and was used here to identify possible correlation between this activity and other biological activities. Specifically, we utilized the standard Limulus Amoebocyte Lysate (LAL) Endosafe Endochrome-K Assay that gives a quantitative detection of endotoxins by kinetic-chromogenic methods. Analyses were performed by Charles River Laboratories, Inc. (Wilmington, MA). Endotoxin activity was expressed as endotoxin unit per mg of LPS (EU/mg). In addition to endotoxin analysis, an enzyme-linked immunosorbent assay (ELISA) specific to the widespread microcystins (MCYSTs), and related nodularins (Abraxis Kits, Warminster, PA), was performed to test for MCYST content in the prepared LPS, and eliminate any possible contribution of this cyanobacterial toxin.
2.3. Breeding and Maintenance of Zebrafish
Zebrafish embryos of the L3 line (obtained from the University of Miami Rosenstiel School of Marine and Atmospheric Science-RSMAS) were used for all experiments presented here. Maintenance and breeding of the zebrafish were carried out by standard methods, and specifically as described by Berry et al. [10,11]. After successful breeding, the eggs were collected, rinsed and placed in a Petri dish with E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4; [24]). Unfertilized and poor quality (i.e., clearly moribund) embryos were removed from the dish and the remaining embryos were subsequently used within 3 hpf (4- to 64-cell stage) for exposures.
2.4. Exposure Studies and Enzyme Assays
For evaluation of detoxifying enzymes, embryos were exposed to 250 μg/L of LPS from E. coli and Microcystis isolates in E3 medium based on a method modified from Cazenave et al. [25] for 24 h. Specifically, 200 embryos per replicate were placed in polystyrene culture dishes, containing LPS (diluted to 250 µg/L) in 30 mL E3 medium; for negative controls, embryos were placed in dishes containing 30 mL of E3 medium only. All exposures were done in triplicate (600 embryos total). The embryos were then “flash frozen” in liquid nitrogen and stored at −80 °C until enzyme extraction. The enzyme preparations were carried out according to the methods of Wiegand et al. [26] by which the samples were mechanically homogenized using phosphate buffer at a pH of 7.4. The cell debris was removed, and the supernatant was collected for enzyme studies. To normalize enzyme activity, total protein content was determined by the “Bradford Assay” [27] using bovine serum albumin as a standard.
Enzyme (GST, GPx, GR, SOD and CAT) activities, as well as total glutathione and relative reduced/oxidized glutathione (GSH/GSSG) were evaluated using commercially available kits (Sigma-Aldrich, St. Louis, MO; Cayman Chemical Company, Ann Arbor, MI), as per manufacturer’s instructions and standard techniques, and expressed relative to total protein. Spectrophotometric measurements were made using a Biotek Synergy HT multi-well plate reader. Total glutathione was determined based on spectrophotometric measure (412 nm) of the production of the 5-thio-2-nitrobenzoic acid (TNB) product; samples were deproteinated using metaphosphoric acid and triethanolamine prior to assays. Oxidized glutathione (GSSG) was specifically determined by derivatizing reduced GSH using 2-vinylpyridine (prior to assays, but following deproteination). GST activity (µmol/mL/min) was measured colorimetrically, specifically based on the conjugation of GSH to 1-chloro-2, 4-dinitrobenzene (CDNB), and subsequent measurement of the product at 340 nm. GPx was measured based on the decrease in NAPDH (340 nm) that is consumed in the recycling of oxidized GSSG to GSH, following reduction of hydroperoxide. GR, on the other hand, was determined, based on the conjugation of GSH to 5,5′-dithiobis(2-nitrobenzoic acid) following recycling of GSSG to the reduced form by GR. Both GPx and GR activity of embryo preparations were compared to standards of purified enzymes. CAT and SOD activity were both determined colorimetrically using kits from Cayman Chemical Company; CAT assays specifically measured the production of formaldehyde (from methanol) using the chromagen, 4-amino-3-hydrazino-5-mercapto-1,2,4-triazole (540 nm), whereas SOD activity was measured based on the dismutation of superoxide radicals, generated by xanthine oxidase, using tetrazolium salts (440 nm).
2.5. Statistics
For the enzymes activities assays, a one-way ANOVA followed by F-test was carried out to determine if LPS treatments were statistically different from the control (p ≤ 0.05).
3. Results and Discussion
3.1. LPS from Microcystis
Cyanobacterial LPS were isolated from laboratory cultures of geographically diverse Microcystis strains, including temperate (MC 81-11 and MC 95-11) and sub-tropical (MC 36-1) representatives. LPS were found to account for up to 4.1% of the dried biomass weight (Table 1). In general agreement with prior studies of heterotrophic bacterial [28] and cyanobacterial [29] LPS, considerable variation in extraction yield (0.1–4.1%) between Microcystis strains was observed (Table 1). In fact, LPS from an additional sub-tropical Microcystis isolate were prepared, but yielded too little for subsequent experimental studies (data not shown).
Table 1.
Cyanobacterial Strain | Source | % Yield of LPS | Endotoxin Activity (×103 EU/mg) |
---|---|---|---|
M. aeruginosa 299 | UTCC a | 0.1 | 107.5 |
MC 36-1 | Doctors Lake, FL | 0.4 | 0.1619 |
MC 81-11 | Lake Ontario | 4.1 | 36.65 |
MC 95-11 | Lake Erie | 2.4 | 6.327 |
a University of Toronto Culture Collection of algae and cyanobacteria.
Endotoxin activities of LPS preparations were measured, using the standard LAL assay, and found to be highly variable (Table 1). Specifically, endotoxin activity (per unit weight, i.e., EU/mg) associated with LPS preparations varied over nearly three orders of magnitude. This variability in endotoxin activity agrees with previous studies [23,30,31] in which the LPS from several, diverse cyanobacterial species were studied, and the endotoxin activities, based on the Limulus assay, likewise, were seen to vary considerably (i.e., 2–3 orders of magnitude).
Indeed, compared to heterotrophic bacterial LPS, little is known about the structural and chemical composition of cyanobacterial LPS, in general, and specifically how chemical composition/structure differences may relate to endotoxin activity. Raziuddin et al. [32] compared LPS from two strains of Microcystis aeruginosa to Salmonella arbortus equi, and found that cyanobacterial LPS had considerably less endotoxin activity than the heterotrophic bacteria (based the LAL assay). More generally, cyanobacterial LPS have been found to be less active in all of the models typically associated with endotoxin activity [8,30].
Only one recent study [33] has provided a complete structural elucidation of a cyanobacterial LPS. Specifically, Snyder et al. [33] characterized the structure of LPS from a marine cyanobacterial genus, Synechococcus. In this study, cyanobacterial LPS (compared to typical heterotrophic bacterial LPS) was found to represent a simplified, and possibly “primordial,” structure. In particular, Synechococcus LPS lacked the usual heptose and Kdo-replaced, instead, by 4-linked glucose-in the oligosaccharide core, and contained a lipid A moiety uniquely characterized by odd-chain hydroxylated fatty acids and lack of phosphates. Similarly, Lindsay et al. [29] recently evaluated LPS preparations from several laboratory strains of cyanobacteria, including Microcystis, and did not detect Kdo in any of the samples evaluated. Unlike preparations from Microcystis, LPS from Synechococcus showed no LAL activity. Taken together with existing toxicological information, these findings strongly suggest that chemical differences relative to heterotrophic bacterial LPS- and particularly, perhaps, the lipid A structure (associated with TLR4-mediated effects; see Introduction) or oligosaccharide core-may underlie the relatively low endotoxin-like activity of cyanobacterial LPS.
In addition to LPS, Microcystis is a well-known producer of the heptapeptide toxin, microcystin. Microcystins have been linked to modulation of each of the detoxification pathways investigated in the present study [34,35,36,37]. Evaluation of LPS preparation using ELISA, specific to the characteristic Adda moiety of microcystins (and related nodularins), suggested that these toxins were not present (within the limit of quantitation, i.e., ≥0.15 ppb) in any of the samples evaluated, and thus not associated with observed effects on detoxification pathways (discussed below).
3.2. Effects of Microcystis LPS on Detoxification Pathways in the Zebrafish Embryo
Relative to heterotrophic bacterial LPS, there have been very limited studies on the toxicology of cyanobacterial LPS. In one very recent study, specifically using LPS isolated from one of the same cyanobacterial strains (i.e., M.aeruginosa 299) investigated here, Mayer et al. [8] showed that cyanobacterial LPS modulates expression of several proinflammatory markers in the rat brain microglia model. However, effects were typically observed at two to three orders of magnitude higher concentrations for cyanobacterial, compared to heterotrophic bacterial, LPS. Similarly, Keleti and Sykora [30] previously showed that cyanobacterial LPS from Oscillatoria brevis and Anabaena cylindrical are about ten times less toxic, in adrenalectomized mice, than heterotrophic bacterial (i.e., Salmonella) LPS.
In addition to these studies, several recent studies (including the present) have specifically investigated the effects of cyanobacterial LPS in various teleost fish models [15,16,37,38]. Unlike mammalian models, teleost fish have been found to either lack, or contain an evolutionarily divergent form of, TLR4 [19] as the recognized mediator of endotoxin, e.g., immunomodulatory, activity [39]. Moreover, this evolutionary divergence of TLR4 has been clearly linked to the resistance of teleost fish to the immunomodulatory effects of heterotrophic bacterial LPS [17,18]. For example, Sepulcre et al. [18] showed that, although heterotrophic bacterial LPS stimulated immunomodulatory effects in zebrafish (which express an evolutionarily divergent TLR4 ortholog, whereas more evolutionarily advanced fish do not), these effects were only observed at significantly (approximately 103-fold) higher doses of LPS, and occurred via TLR4-independent pathways.
In the present study, we evaluated the effects of LPS from Microcystis in relation to several detoxification enzymes/pathways in the zebrafish embryo model. No difference in mortality, or apparent impairment of development, was observed in zebrafish embryos exposed to any of the LPS treatments. However, a significant modulation of several detoxifying pathways was measured.
GST activity decreased after 24 h exposure of zebrafish embryos to both heterotrophic bacterial and cyanobacterial LPS (at 250 µg/L). Compared to the control group (0.15 nkatal/mg protein), GST activity was significantly decreased in embryos that were exposed to E. coli (0.076 nkatal/mg protein), M. aeruginosa 299 (0.078 nkatal/mg protein), MC 36-1 (0.11 nkatal/mg protein) and MC 81-11 (0.056 nkatal/mg protein) LPS. Embryos exposed to MC 95-11 LPS showed a decrease (0.12 nkatal/mg protein), although it was not statistically significant (Figure 1). Inhibition of GST (compared to “No LPS” controls) varied considerably between LPS preparations, ranging 61.9% inhibition for the most active (MC 81-11) to approximately 20–25% for the least active (20.6% and 25.5%, respectively for MC 95-11 and MC 36-1).
Inhibition of GST is consistent with prior studies in zebrafish and other teleost fish models [15,37,38]. Best et al. [15] similarly demonstrated GST inhibition by cyaonbacterial LPS in the zebrafish embryo model. More recently, Wang et al. [37] found apparent down-regulation of GST mRNA in response to LPS in the Nile tilapia (Oreochromis niloticus).
In addition to GST, we also investigated two additional enzymes, GPx and GR, which reciprocally utilize glutathione, and specifically recycle the peptide between its reduced and oxidized forms. While no effects of LPS on GR were observed, GPx moderately increased in zebrafish embryos exposed to all LPS evaluated (Figure 2). GPx showed a significant increase from the controls (0.07 nkatal/mg protein) in embryos exposed to E. coli (0.13 nkatal/mg protein), and MC 95-11 (0.13 nkatal/mg protein). Though increases in the embryos exposed to M. aeruginosa 299 (0.12 nkatal/mg protein), MC 36-1 (0.11 nkatal/mg protein), and MC 81-11 (0.12 nkatal/mg protein) were observed, they were not statistically significant (Figure 2). To the authors’ knowledge, this is the first report of the effect of LPS on GPx in the zebrafish embryo model. However, this is consistent with prior studies of tilapia by Wang et al. [37] who, likewise, showed a moderate up-regulation of GPx transcription by LPS.
In order to evaluate the role of oxidative stress, as well as the possible effects of LPS on glutathione levels, in relation to the modulation of GST and GPx, we measured both total glutathione, as well as relative ratios of reduced (GSH) and oxidized (GSSG) forms. Heterotrophic bacterial LPS is associated with oxidative stress in multiple model systems [40]. The relative concentration of GSH/GSSG, and specifically a decrease in this ratio—due to the relative depletion of GSH, and subsequent accumulation of the oxidized GSSG—has been widely employed as an indicator of oxidative stress in a range of organisms [41], including zebrafish [42]. In agreement with this, we observed a slight, but not statistically significant, decrease in GSH/GSSG ratio (Figure 3) in embryos exposed to E. coli LPS (Figure 3). The slightness of the effect would be consistent with prior studies [19] which indicate teleost fish, and specifically zebrafish, are generally resistant to TLR4-mediated effects (e.g., immunomodulatory, oxidative stress) of heterotrophic bacteria LPS.
In contrast, we actually observed an increase, although not statistically significant, in the ratio of reduced/oxidized glutathione in embryos exposed to cyanobacterial LPS (Figure 3), suggesting an alternative mechanism, and not oxidiative stress, for concomitant modulation of GST and GPx (see below). In further support of this, no change in either SOD or CAT activity was observed (data not shown) in embryos exposed to LPS. Unlike GST and GPx that primarily act via interaction with ROS-generating xenobiotics or products of oxidative damage (e.g., lipid peroxides), both SOD and CAT directly detoxify ROSs (i.e., superoxide and hydrogen peroxide, respectively), and are thus generally associated most directly with oxidative stress.
Rather than oxidative stress, cyanobacterial LPS increased both total glutathione and reduced GSH (Figure 4) levels in exposed embryos. Embryos exposed to all cyanobacterial LPS treatments showed a significant increase total glutathione pool (i.e., both GSH and GSSG; Figure 4A), relative to the untreated (i.e., “No LPS”) controls (7.28 µM). In contrast, there was no significant increase-and, in fact, a slight decrease (7.22 µM)-in total glutathione for embryos exposed to E. coli LPS (Figure 4A). Exclusive measurements of reduced and oxidized glutathione determined that GSSG content showed no significant difference compared to the control, but a significant increase in GSH content for embryos exposed to LPS from M. aeruginosa 299 (5.86 µM, p < 0.05), MC 81-11 (6.33 µM, p < 0.01), and MC 95-11 (6.21 µM, p < 0.01) (Figure 4B). GSH levels also increased, relative to controls (5.42 µM) in embryos exposed to LPS from MC 36-1 (5.68 µM), as well as E. coli (5.70 µM), but increases were not statistically significant.
These results, taken together, support an alternative mechanism (i.e., not oxidative stress), and perhaps a possible direct interaction between LPS and glutathione-based detoxification pathways. The increase in total glutathione pool (Figure 4A) clearly suggests that cyanobacterial LPS either directly or indirectly elevate levels of the peptide. In support of a direct interaction between LPS and GST expression, and consequent activity, Wang et al. [37] cloned the putative soluble GST-α gene from tilapia—the transcription of which was shown to increase with LPS exposure-and identified a putative “LPS response element.” Comparison to the sequence of a GST-α (BC056725) cloned from zebrafish, in fact, identifies a similar sequence, and further supports the possible involvement of transcription level regulation of GST by LPS in this model. Likewise, the same study showed a concomitant increase in GPx transcription (in the trout model) with LPS exposure, in agreement with moderate effects on GPx activity observed here.
4. Conclusions
Although cyanobacterial LPS are ubiquitous, particularly in freshwater habitats, very few toxicological studies have investigated their relevant bioactivities (particularly relative to heterotrophic bacterial “endotoxin”). In the current study, we utilized the zebrafish embryo, as a toxicological model, to investigate the effects of LPS from the widespread cyanobacterial genus, Microcystis, on several detoxification enzymes/pathways.
These studies demonstrate that cyanobacterial LPS modulate glutathione-based detoxification pathways including apparent inhibition of GST activity, stimulation of GPx activity and elevation of total and reduced glutathione. Moreover, whereas a possible role of oxidative stress (as evidenced by reduced GSH/GSSG ratio) was suggested for heterotrophic bacterial LPS, an observed increase in GSH and GSH/GSSG ratio in zebrafish embryos exposed to cyanobacterial LPS suggests an alternative mechanism, and perhaps a direct interaction with glutathione-based enzymes/pathways. In the case of GST and GPx, this is supported by prior studies in tilapia [37] that documented transcriptional level effects of LPS on both enzymes. On the other hand, possible mechanisms for the observed increase in glutathione levels, including direct effects (e.g., stimulation of glutathione biosynthesis) or indirect effects (e.g., accumulation of GSH associated with GST inhibition), remain to be investigated. Moreover, the alternative mechanism suggested here (i.e., interaction with glutathione-based pathways), specifically in relation to previously identified differences between heterotrophic and cyanobacterial LPS chemical composition (e.g., lipid A and lack of Kdo; [29,33]), and between mammalian and teleost fish systems (i.e., absence of TLR4 in the latter; [19]), more generally indicates a possibly novel toxicophore for cyanbacterial LPS in teleost fish. Further chemical characterization of cyanobacterial LPS, in relation to relevant activities, are needed to address this possibility.
Finally, the observed effects of LPS on glutathione-based detoxification pathways may explain previously observed interactive effects of LPS with other toxicants. In particular, cyanobacteria produce a wide array of toxic or otherwise bioactive metabolites, including several recognized toxins (e.g., microcystins, cylindrospermopsin, anatoxin-a, saxitoxin). In the case of the widespread hepatotoxin, microcystin (also produced by Microcystis), for example, detoxification has been clearly linked to GST conjugation of GSH to the toxin [43,44,45]. As such, modulation of these detoxification pathways by LPS could present an interactive role with toxicity. In agreement with this, Best et al. [46] more recently found that co-exposure of trout to microcystin and LPS significantly increased the toxicity of the former (as measured by hepatosomatic index). It is proposed that such a finding could be explained by, for example, reduced detoxification capacity (e.g., GST inhibition) associated with LPS exposure. Similarly, interactive effects between LPS and cyanobacterial toxins, including microcystins and cylindrospermopsin, have been observed in aquatic invertebrates, and particularly Daphnia [47,48]. In the case of cylindrospermopsin, it has been shown that the toxin actually inhibits synthesis of reduced GSH [49], and as mentioned previously, microcystin detoxification is recognized to involve GST conjugation [43,44,45]. Interestingly, however, it was shown that co-exposure, in the case of Daphnia, to cyanobacterial LPS and microcystin or cylindrospermopsin had, in fact, a protective effect against these latter toxins. An interactive role would be obviously relevant to toxicological studies of these cyanobacterial toxins as, in natural settings (e.g., freshwater systems), organisms would be exposed to not only the toxins, but cellular LPS (as components of all cyanobacterial cell walls). However, further studies are required to clarify the complexities of these possible interactions.
Acknowledgements
This work was supported by an NIH/NIEHS R21 Exploratory/Developmental Research Grant (ES014 037). This research was conducted as partial fulfillment of the requirements for the Degree of Master of Science (A. Jaja).
Conflict of Interest
The authors declare no conflict of interest.
References
- 1.Codd G., Morrison L., Metcalf J. Cyanobacterial toxins: Risk management for health protection. Toxicol. Appl. Pharmacol. 2005;203:264–272. doi: 10.1016/j.taap.2004.02.016. [DOI] [PubMed] [Google Scholar]
- 2.Brooks G.F., Carroll K.C., Butel J.S., Morse S.A., Mietzner T.A. Jawetz, Melnick & Adelberg’s Medical Microbiology. 24th. McGraw-Hill Medical; New York, NY, USA: 2007. [Google Scholar]
- 3.Saluk-Jusczak J., Wachowicz B. The proinflammatory activity of lipopolysaccharide. Postepy. Biochem. 2005;51:280–287. [PubMed] [Google Scholar]
- 4.Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 2008;15:164–187. doi: 10.1159/000136357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science. 1998;282:2085–2088. doi: 10.1126/science.282.5396.2085. [DOI] [PubMed] [Google Scholar]
- 6.Yamamoto M., Akira S. Lipid A Receptor TLR4-Mediated Signaling Pathways. In: Jeannin J.F., editor. Lipid A in Cancer Therapy. 1st. Springer Verlag; Berlin, Germany: 2009. pp. 59–68. [DOI] [PubMed] [Google Scholar]
- 7.Stewart I., Schluter P., Shaw G. Cyanobacterial lipopolysaccharides and human health—A review. Environ. Health. 2006;5:7. doi: 10.1186/1476-069X-5-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Mayer A.M.S., Clifford J.A., Aldulescu M., Frenkel J.A., Holland M.A., Hall M.L., Glaser K.B., Berry J. Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B2, cytokines, chemokines and matrix metalloproteinase-9 by rat microglia. Toxicol. Sci. 2011;121:63–72. doi: 10.1093/toxsci/kfr045. [DOI] [PubMed] [Google Scholar]
- 9.Linney E., Upchurch L., Donerly S. Zebrafish as a Neurotoxicological Model. Neurotoxicol. Teratol. 2004;26:709–718. doi: 10.1016/j.ntt.2004.06.015. [DOI] [PubMed] [Google Scholar]
- 10.Berry J., Gantar M., Gibbs P., Schmale M. The zebrafish (Danio rerio) embryo as a model system for identification and characterization of developmental toxins from marine and freshwater microalgae. Comp. Biochem. Physiol. 2007;145:61–72. doi: 10.1016/j.cbpc.2006.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Berry J., Gibbs P., Schmale M., Saker M. Toxicity of cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo. Toxicon. 2009;53:289–299. doi: 10.1016/j.toxicon.2008.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dodd A., Curtis P., Williams L., Love D. Zebrafish: Bridging the gap between development and disease. Hum. Molec. Genet. 2000;9:2443–2449. doi: 10.1093/hmg/9.16.2443. [DOI] [PubMed] [Google Scholar]
- 13.Zhu H., Zon L.I. Use of zebrafish models for the analysis of human disease. Curr. Protoc. Hum. Genet. 2002;15:1–9. doi: 10.1002/0471142905.hg1503s34. [DOI] [PubMed] [Google Scholar]
- 14.Rocke J., Lees J., Packham I., Chico T. The zebrafish as a novel tool for cardiovascular drug discovery. Recent Pat. Cardiovasc. Drug Discov. 2009;4:1–5. doi: 10.2174/157489009787260043. [DOI] [PubMed] [Google Scholar]
- 15.Best J.H., Pflugmacher S., Weigand C., Eddy F.B., Metcalf J.S., Codd G.A. Effects of enteric bacterial and cyanobacterial lipopolysaccharides, and of microcystin-LR, on glutathione S-transferase activities in zebrafish (Danio rerio) Aquat. Toxicol. 2002;60:223–231. doi: 10.1016/S0166-445X(02)00010-3. [DOI] [PubMed] [Google Scholar]
- 16.Notch E.G., Miniutti D.M., Patenaude C.A., Berry J.P., Mayer G.D. Cyanobacterial LPS potentiates cadmium toxicity in zebrafish (Danio rerio) embryos. Environ. Toxicol. 2011;26:498–505. doi: 10.1002/tox.20578. [DOI] [PubMed] [Google Scholar]
- 17.Berczi I., Bertok L., Berznai T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 1966;12:1070–1071. doi: 10.1139/m66-143. [DOI] [PubMed] [Google Scholar]
- 18.Novoa B., Bowman T.V., Zon L., Figueras A. LPS response and tolerance in the zebrafish. Fish Shellfish Immunol. 2009;26:326–331. doi: 10.1016/j.fsi.2008.12.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sepulcre M.P., Alcaraz-Perez F., Lopez-Munoz A., Roca F.J., Meseguer J., Cayuela M.L., Mulero V. Evolution of lipopolysaccharide (LPS) recognition and signaling: Fish TLR4 does not recognize LPS and negatively regulates NF-kappaB activation. J. Immunol. 2009;182:1836–1845. doi: 10.4049/jimmunol.0801755. [DOI] [PubMed] [Google Scholar]
- 20.Komarek J., Anagnostidis K. Modern approach to the classification system of cyanophytes 2: Chroococcales. Arch. Hydrobiol. Algol. Stud. 1986;43:157–226. [Google Scholar]
- 21.Komarek J., Anagnostidis K. Modern approach to the classification system of cyanophytes 2: Nostocales. Arch. Hydrobiol. Algol. Stud. 1989;56:247–345. [Google Scholar]
- 22.Gantar M., Berry J., Thomas S., Wang M., Perez R., Rein K. Cyanobacterial toxins as allelochemicals with potential applications as algaecides, herbicides and insecticides. FEMS Microbiol. Ecol. 2008;64:55–64. doi: 10.1111/j.1574-6941.2008.00439.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bernadova K., Babica P., Marsalek B., Blaha L. Isolation and endotoxin activities of lipopolysaccharides from cyanobacterial cultures and complex water blooms and comparison with the effects of heterotrophic bacteria and green alga. J. App. Toxicol. 2008;28:72–77. doi: 10.1002/jat.1257. [DOI] [PubMed] [Google Scholar]
- 24.Brand M., Granato M., Nusslein-Volhard C. In: Zebrafish. Nusslein-Volhard C., Dahm R., editors. Oxford University Press; Tubingen, Germany: 2002. pp. 7–37. [Google Scholar]
- 25.Cazenave J., Bistoni M., Zwirnmann E., Wunderlin D., Wiegand C. Attenuating effects on natural organic matter on microcystin toxicity in zebrafish (Danio rerio) embryos. Envir. Toxicol. 2006;21:22–32. doi: 10.1002/tox.20151. [DOI] [PubMed] [Google Scholar]
- 26.Wiegand C., Pflugmacher S., Oberemm A., Meems N., Beattie K., Steinberg C., Codd G. Uptake and effects of microcystin-LR on detoxication enzymes of early life stages of the zebrafish (Danio rerio) Environ. Toxicol. 1999;14:89–95. doi: 10.1002/(SICI)1522-7278(199902)14:1<89::AID-TOX12>3.0.CO;2-7. [DOI] [Google Scholar]
- 27.Bradford M.M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- 28.Moran A.P., Helander I.M., Kosunen T.U. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 1992;174:1370–1377. doi: 10.1128/jb.174.4.1370-1377.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lindsay J., Metcalf J.S., Codd G.A. Comparison of four methods for the extraction of lipopolysaccharide from cyanobacteria. Toxicol. Environ. Chem. 2009;91:1253–1262. doi: 10.1080/02772240802607394. [DOI] [Google Scholar]
- 30.Keleti G., Sykora J. Production and properties of cyanobacterial endotoxins. Appl. Environ. Microbiol. 1982;43:104–109. doi: 10.1128/aem.43.1.104-109.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Papageorgiou J., Linke T.A., Kapralos C., Nicholson B.C., Steffensen D.A. Extraction of cyanobacterial endotoxin. Environ. Toxicol. 2004;19:82–87. doi: 10.1002/tox.10152. [DOI] [PubMed] [Google Scholar]
- 32.Raziuddin S., Siegelman H., Tornabene T. Lipopolysaccharides of the cyanobacterium Microcystis aeruginosa. Eur. J. Biochem. 1983;137:333–336. doi: 10.1111/j.1432-1033.1983.tb07833.x. [DOI] [PubMed] [Google Scholar]
- 33.Snyder D.S., Brahamsha B., Azadi P., Palenik B. Structure of compositionally simple lipopolysaccharide from marine Synechococcus. J. Bacteriol. 2009;191:5499–5509. doi: 10.1128/JB.00121-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chen J., Song L., Dai J., Gan N., Liu Z. Effects of microcystins on the growth and activity of superoxide dismutase and peroxidase of rape (Brassica napus) and rice (Oryza sativa) Toxicon. 2004;43:393–400. doi: 10.1016/j.toxicon.2004.01.011. [DOI] [PubMed] [Google Scholar]
- 35.Gehringer M.M., Shephard E.G., Downing T.G., Wiegand C., Neilan B.A. An investigation into the detoxification of microcystin-LR by the glutathione pathway in Balb/c mice. Int. J. Biochem. Cell Biol. 2004;36:931–941. doi: 10.1016/j.biocel.2003.10.012. [DOI] [PubMed] [Google Scholar]
- 36.Cazenave J., Bisotoni M., Pesce S.F., Wunderlin A. Differential detoxification and antioxidant response in diverse organs of Corydoras paleatus experimentally exposed to microcystin-RR. Aquat. Toxicol. 2006;76:1–12. doi: 10.1016/j.aquatox.2005.08.011. [DOI] [PubMed] [Google Scholar]
- 37.Wang L., Liang X.-F., Liao W.-Q., Lei L.-M., Han B.-P. Structural and functional characterization of microcystins detoxification-related liver genes in a phytoplanktivorous fish, nile tilapia (Oreochromis niloticus) Comp. Biochem. Physicol. Part C Toxicol. Pharmacol. 2006;144:216–227. doi: 10.1016/j.cbpc.2006.08.009. [DOI] [PubMed] [Google Scholar]
- 38.Mayer G., Berry J., Patenaude C., Walsh P. Effect of lipopolysaccharides from Microcystis and Lyngbya on metal toxicity in Fundulus heteroclitus. Bull. MDIBL. 2004;43:143–144. [Google Scholar]
- 39.Aderem A., Ulevitch R.J. Toll-Like receptors in the induction of the innate immune response. Nature. 2000;406:782–787. doi: 10.1038/35021228. [DOI] [PubMed] [Google Scholar]
- 40.Müller J.M., Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 1993;187:233–256. doi: 10.1016/S0171-2985(11)80342-6. [DOI] [PubMed] [Google Scholar]
- 41.Owen J.B., Butterfield D.A. Measurement of oxidized/reduced glutathione ratio. Meth. Mol. Biol. 2010;648:269–277. doi: 10.1007/978-1-60761-756-3_18. [DOI] [PubMed] [Google Scholar]
- 42.Carvan M.J., Sonntag D.M., Cmar C.B., Cook R.S., Curran M.A., Miller G.L. Oxidative stress in zebrafish cells: potential utility of transgenic zebrafish as deployable sentinel for site hazard ranking. Sci. Total Environ. 2001;274:183–196. doi: 10.1016/S0048-9697(01)00742-2. [DOI] [PubMed] [Google Scholar]
- 43.Kondo F., Matsumoto H., Yamada S., Ishikawa N., Ito E., Nagata S., Ueno Y., Suzuki M., Harada K. Detection and identification of metabolites of microcystins formed in vivo in mouse and rat livers. Chem. Res. Toxicol. 1996;9:1355–1359. doi: 10.1021/tx960085a. [DOI] [PubMed] [Google Scholar]
- 44.Pflugmacher S., Wiegand C., Oberemm A., Keattie K.A., Krause E., Codd G.A., Steinberg C.E.W. Identification of an enzymatically formed glutathione conjugate of the cyanobacterial hepatotoxin microcystin LR; the first step in detoxification. Biochim. Biophys. Acta. 1998;1425:527–533. doi: 10.1016/S0304-4165(98)00107-X. [DOI] [PubMed] [Google Scholar]
- 45.Takenaka S. Covalent glutathione conjugation to cyanobacterial hepatotoxin microcystin LR by F344 rat cytosolic and microsomal glutathione-S-transferases. Environ. Toxicol. Pharmacol. 2001;9:135–139. doi: 10.1016/S1382-6689(00)00049-1. [DOI] [PubMed] [Google Scholar]
- 46.Best J.H., Eddy F.B., Codd G.A. Effects of microcystis cells, cell extracts and lipopolysaccharide on drinking and liver function in rainbow trout oncorhynchus mykiss walbaum. Aquat. Toxicol. 2003;64:419–426. doi: 10.1016/S0166-445X(03)00105-X. [DOI] [PubMed] [Google Scholar]
- 47.Lindsay J., Metcalf J.S., Codd G.A. Protection against the toxicity of microcystin-LR and cylindrospermopsin in Artemia salina and Daphnia spp. by pre-treatment with cyanobacterial lipopolysaccharide (LPS) Toxicon. 2006;48:995–1001. doi: 10.1016/j.toxicon.2006.07.036. [DOI] [PubMed] [Google Scholar]
- 48.Dionisio-Pires L.M., Sarpe D., Brehm M., Ibelings B.W. Potential synergistic effects of microcystins and bacterial lipopolysaccharides on life history traits of Daphnia galeata raised on low and high food levels. Aquat. Toxicol. 2011;104:230–242. doi: 10.1016/j.aquatox.2011.05.001. [DOI] [PubMed] [Google Scholar]
- 49.Runnegar M.T., Kong S.M., Zhong Y.Z., Lu S.C. Inhibition of reduced glutathione synthesis by cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem. Pharmacol. 1995;49:219–225. doi: 10.1016/s0006-2952(94)00466-8. [DOI] [PubMed] [Google Scholar]